Post marketing reports via MedWatch suggest a link berween Singulair (montelukast) and possibly the two other approved drugs which act on the leukotriene pathway (Accolate aka zafirlukast and Zyflo aka zileuton). The FDA continues to monitor post marketing reports and is examining clinical trial data.
Via Medscape.
No comments:
Post a Comment